HDII (Hypertension Diagnostics) Cash Flow from Financing: $0.00 Mil (TTM As of Sep. 2019)

Hypertension Diagnostics  (OTCPK:HDII) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Hypertension Diagnostics's issuance of stock for the three months ended in Sep. 2019 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Hypertension Diagnostics's repurchase of stock for the three months ended in Sep. 2019 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Hypertension Diagnostics's net issuance of debt for the three months ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Hypertension Diagnostics's net issuance of preferred for the three months ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Hypertension Diagnostics's cash flow for dividends for the three months ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Hypertension Diagnostics's other financing for the three months ended in Sep. 2019 was $0.00 Mil. Hypertension Diagnostics received $0.00 Mil on other financial activities.

Hypertension Diagnostics Cash Flow from Financing Related Terms

The historical data trend for Hypertension Diagnostics's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Cash Flow from Financing Chart

Hypertension Diagnostics Annual Data
	Trend	Jun06	Jun07	Jun08	Jun09	Jun10	Jun11	Jun12	Dec16	Dec17	Dec18
Cash Flow from Financing		Get a 7-Day Free Trial					0.03	0.93	0.26	0.18	0.19

Hypertension Diagnostics Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Dec16	Dec17	Dec18	Mar19	Jun19	Sep19
Cash Flow from Financing	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

Hypertension Diagnostics Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Hypertension Diagnostics's Cash from Financing for the fiscal year that ended in Dec. 2018 is calculated as:

Hypertension Diagnostics's Cash from Financing for the quarter that ended in Sep. 2019 is:

Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypertension Diagnostics Business Description